Sign in

    Bryan Ball

    Chief Technical Operations Officer at AADI
    Since March 2024
    Age
    55 years
    Education
    Holds a B.Sc. in Biology from Central Michigan University, an M.Sc. in Cell Biology from the University of North Carolina at Charlotte, and an M.B.A. from Westminster College.
    Tenure
    Joined AADI in August 2022 as Chief Quality Officer and Senior Vice President, Manufacturing Operations, and was promoted to Chief Technical Operations Officer in March 2024.

    Also at AADI

    SG
    Scott Giacobello
    CFO and Treasurer

    About

    Bryan Ball has built a robust career in the biopharmaceutical and pharmaceutical sectors, consistently focusing on quality and operational excellence throughout his leadership roles at companies such as Intercept Pharmaceuticals, Immunomedics, Mallinckrodt Pharmaceuticals, Ikaria, and Boehringer Ingelheim.

    He developed comprehensive expertise in managing quality control, operational strategies, and technical processes, which has underpinned his progression from senior operational roles to executive leadership positions.

    At AADI Bioscience, his strategic vision has significantly enhanced manufacturing operations and quality assurance standards. His contributions have been central to aligning technical innovation with industry compliance, further establishing his reputation as a transformative leader in the sector.

    Past Roles

    OrganizationRoleDate RangeDetails
    Aadi Bioscience Chief Quality Officer and Senior Vice President, Manufacturing Operations Aug 2022 - Mar 2024 Ended upon promotion to Chief Technical Operations Officer
    Aadi Bioscience Executive Officer Year ended Dec 31, 2022 Held for the year 2022
    Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) Chief Quality Officer and Senior Vice President, Operations Jan 2021 - Aug 2022 Oversaw quality issues, product development, clinical trials, manufacturing, testing, and distribution
    Immunomedics, Inc. Chief Quality Officer Mar 2019 - Dec 2020 Managed quality for clinical stage candidates and the first commercial product
    Mallinckrodt Pharmaceuticals Senior Vice President for Quality, Environmental Health, and Safety 2015 - 2019 Oversaw quality, environmental health, and safety functions
    Ikaria, Inc. (now part of Mallinckrodt Pharmaceuticals) Vice President for Global Quality 2012 - 2015 N/A
    Boehringer Ingelheim Vice President for Quality Operations 2008 - 2012 N/A

    Fixed Compensation

    Data from  FY 2022
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$445,000 Periodic payroll in accordance with the company's normal payroll practices Annual salary for employment services and subject to applicable withholdings
    Sign-On Bonus$65,000 One-time payment shortly after employment start date Repayable within 30 days of termination if voluntary separation occurs within 18 months

    Performance Compensation

    Data from  FY 2022

    No information available on performance compensation for 2022.